Abstract
St. John's wort (Hypericum perforatum; SJW), traditionally used for a variety of nervous system conditions, is a popular modern-day herbal treatment for depression. Many clinical trials consistently demonstrate SJW's effectiveness in major depressive disorder (MDD); several have shown it to be equivalent to pharmaceutical antidepressants (Sarris 2013). However, because most of these studies used highly characterized, standardized SJW preparations, the findings cannot be extrapolated to all over-the-counter SJW supplements. In this chapter, I discuss the mechanisms of action of SJW, emerging pharmacogenetic data, current evidence of the efficacy of SJW in treating depression, safety and clinical considerations, and a case study.
Original language | English |
---|---|
Title of host publication | Complementary and Integrative Treatments in Psychiatric Practice |
Editors | Patricia L. Gerbarg, Philip R. Muskin, Richard P. Brown |
Place of Publication | U.S. |
Publisher | American Psychiatric Association |
Pages | 143-148 |
Number of pages | 6 |
ISBN (Electronic) | 9781615371358 |
ISBN (Print) | 9781615370313 |
Publication status | Published - 2017 |
Keywords
- St John's wort
- depression, mental